Cargando…

Antimicrobial Management of Disseminated Strongyloidiasis in a COVID-19 Patient

Detalles Bibliográficos
Autores principales:	Lier, Audun J., Davis, Matthew W., Topal, Jeffrey E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2020
Materias:	In Response
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646765/ https://www.ncbi.nlm.nih.gov/pubmed/33174527 http://dx.doi.org/10.4269/ajtmh.20-1059b

Ejemplares similares

Case Report: Disseminated Strongyloidiasis in a Patient with COVID-19
por: Lier, Audun J., et al.
Publicado: (2020)

Gastroduodenal involvement in disseminated strongyloidiasis
por: Minamide, Tatsunori, et al.
Publicado: (2018)

A CASE OF DISSEMINATED STRONGYLOIDIASIS DURING TREATMENT FOR COVID-19
por: PATEL, ANJALI, et al.
Publicado: (2021)

Concurrent Antibiotic Therapy in Disseminated Strongyloidiasis
por: Kow, Chia Siang, et al.
Publicado: (2020)

Disseminated Strongyloidiasis in Association with Nephrotic Syndrome
por: Abdullah, Amirahwaty, et al.
Publicado: (2018)

Disseminated Strongyloidiasis: Breaking Brain Barriers
por: Sebastian, Ivy Anne, et al.
Publicado: (2019)

Fatal Disseminated Strongyloidiasis with Periumbilical Purpura
por: Pivoto João, Guilherme Augusto, et al.
Publicado: (2021)

Fatal Disseminated Strongyloidiasis in Steroid Overuse
por: Rajakumar, Priyadarshini, et al.
Publicado: (2023)

Disseminated Strongyloidiasis in a Patient with Membranoproliferative Glomerulonephritis-Case Report
por: MALAKOUTIAN, Tahereh, et al.
Publicado: (2015)

Disseminated Strongyloidiasis in an Iranian Immunocompromised Patient: A Case Report
por: NAJAFI, Narges, et al.
Publicado: (2016)

Clinical Characteristics of Disseminated Strongyloidiasis, Japan, 1975–2017
por: Mukaigawara, Mitsuru, et al.
Publicado: (2020)

Disseminated strongyloidiasis in a patient with rheumatoid arthritis: A case report
por: Zheng, Jin-Hao, et al.
Publicado: (2022)

Reply to ‘Delirium, sleep, COVID-19 and melatonin’
por: D'Agostino, Armando, et al.
Publicado: (2020)

A case of fatal disseminated strongyloidiasis accompanied with intestinal obstruction
por: Heydarian, Peyman, et al.
Publicado: (2019)

A case of disseminated strongyloidiasis after multiple courses of immunosuppression
por: Mah, Jordan, et al.
Publicado: (2022)

COVID-19 economic impact payments and opioid overdose deaths: A response
por: Sprague, Jon E., et al.
Publicado: (2022)

Re: “Re: Diagnostic Accuracy of Global Pharma Health Fund Minilab(™) in Assessing Pharmacopoeial Quality of Antimicrobials”
por: Pan, Hui, et al.
Publicado: (2018)

Human rights and COVID-19 triage: a comment on the Bath protocol
por: Bhatt, Vivek, et al.
Publicado: (2021)

Pulmonary Hemorrhage Secondary to Disseminated Strongyloidiasis in a Patient with Systemic Lupus Erythematosus
por: Plata-Menchaca, Erika P., et al.
Publicado: (2015)

Response to Letter from Dr. Volbeda and Colleagues Regarding COVID-19 and CKD
por: Sörling, Annika, et al.
Publicado: (2023)

Author's response to “Continuous positive airway pressure helmet in patients with ARDS due to COVID-19 pneumonia: Insights about a therapy monitoring protocol”
por: Privitera, Daniele, et al.
Publicado: (2022)

Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19 (Diabetes Metab J 2021;45:251-9)
por: Rhee, Sang Youl
Publicado: (2021)

Methylprednisolone/tocilizumab: Disseminated strongyloidiasis and off-label use: case report
Publicado: (2020)

Diagnostic value of metagenomics next-generation sequencing technology in disseminated strongyloidiasis
por: Song, Peng, et al.
Publicado: (2022)

Safety of COVID-19 Vaccines among Patients with Type 2 Diabetes Mellitus: Real-World Data Analysis (Diabetes Metab J 2023;47:356-65)
por: Kim, Hye Jun, et al.
Publicado: (2023)

A Unique Patient Presentation of Disseminated Strongyloidiasis: Unraveling the Clinical Complexity of an Immunocompromised Patient
por: Shtanko, Yulia, et al.
Publicado: (2023)

Strongyloidiasis: An Important Coinfection in the COVID-19 Era
por: Núñez-Gómez, Laura, et al.
Publicado: (2021)

A fatal combination of disseminated strongyloidiasis with two bacterial infections in an immunocompromised host
por: Vini, Vineeta, et al.
Publicado: (2021)

Response: Precise Pulmonary Function Evaluation and Management of a Patient With Freeman-Sheldon Syndrome Associated With Recurrent Pneumonia and Chronic Respiratory Insufficiency (Ann Rehabil Med 2020;44:165-70)
por: Park, Jihyun, et al.
Publicado: (2020)

Disseminated Strongyloidiasis in an Immunodeficient Patient (Pemphigus Vulgaris) Due to Corticosteroid Therapy: A Case Report
por: NAJJARI, Mohsen, et al.
Publicado: (2016)

Fatal Outcome of Disseminated Strongyloidiasis despite Detectable Plasma and Cerebrospinal Levels of Orally Administered Ivermectin
por: Rose, Charles E., et al.
Publicado: (2009)

Reply to comments on prone CPR for COVID-19 patients
por: Singh, Baljit, et al.
Publicado: (2020)

Response: Association between Cardiac Autonomic Neuropathy, Diabetic Retinopathy and Carotid Atherosclerosis in Patients with Type 2 Diabetes (Endocrinol Metab 2013;28:309-19, Chan-Hee Jung et al.)
por: Jung, Chan-Hee, et al.
Publicado: (2014)

COVID-19 and strongyloidiasis: what to expect from this coinfection?
por: Pereira, Carolina Victoria Marcitelli, et al.
Publicado: (2021)

Fetal Abdominal Obesity Detected at 24 to 28 Weeks of Gestation Persists until Delivery Despite Management of Gestational Diabetes Mellitus (Diabetes Metab J 2021;45:547-57)
por: Kim, Wonjin, et al.
Publicado: (2021)

Strongyloidiasis—An Insight into Its Global Prevalence and Management
por: Puthiyakunnon, Santhosh, et al.
Publicado: (2014)

Response: Acute Hyperglycemic Crises with Coronavirus Disease-19: Case Reports (Diabetes Metab J 2020;44:349–53)
por: Kim, Na-young, et al.
Publicado: (2020)

Response to Comment on: “Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients”
por: Brown, Jennifer R.
Publicado: (2021)

Awareness of Genetic Polymorphism in Drug Metabolizing Enzymes and Transporters May Promote Personalized Type 2 Diabetes Management [Response to Letter]
por: Williams, David M, et al.
Publicado: (2022)

Response to “Comments on Economic Evaluation of Ultrasound-guided Central Venous Catheter Confirmation vs Chest Radiography in Critically Ill Patients: A Labor Cost Model”
por: Ablordeppey, Enyo A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hvrp9joe7t8djupbhfgc6odu8v